Make An Appointment

Physician Location Contact

Bladder Cancer Clinical Trials

Bladder cancer is the sixth most common cancer in the United States. Bladder cancer is estimated to be the most costly cancer in the US, and treatment-related complications are estimated to account for one-third of total costs. Approximately 70-80% of patients have non-muscle invasive bladder cancer (NMIBC) at the time of diagnosis

If you have recently been diagnosed with NMIBC or have had a recurring diagnosis you may qualify to participate in a clinical trial. Our trials are open to both male and female patients.

For eligibility purposes please be advised that medical records will be requested and reviewed for confirmation.

If you think you might qualify for a Bladder Cancer Clinical Trial email or call 310-602-5018 and a research coordinator will respond to your request within 48 hours.

Learn more about: